诺禾致源中标单细胞转录组二代测序项目券商积极评价彰显成长潜力

自选股中标信息07-31

2025年07月31日，据天眼查数据，单细胞转录组二代测序（WLU-FW-KS-NM-2025-0795）成交结果公告显示，中标方为诺禾致源（sh688315），招标方为西湖大学。近半年内，诺禾致源获得6家券商积极评价：国盛证券和银河证券给予"买入"评级。浙商证券给予"增持"评级。诺禾致源主营业务涵盖测序平台服务（占比约50.00%），生命科学基础科研服务（占比约33.98%），医学研究与技术服务...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2555887903?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-07-31 19:01","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2555887903","market":"sh","top_or_hot":-1,"title":"诺禾致源中标单细胞转录组二代测序项目 券商积极评价彰显成长潜力","media":"自选股中标信息","content":"<div>\n<p>2025年07月31日，据天眼查数据，单细胞转录组二代测序（WLU-FW-KS-NM-2025-0795）成交结果公告显示，中标方为诺禾致源（sh688315），招标方为西湖大学。近半年内，诺禾致源获得6家券商积极评价：国盛证券和银河证券给予\"买入\"评级。浙商证券给予\"增持\"评级。诺禾致源主营业务涵盖测序平台服务（占比约50.00%），生命科学基础科研服务（占比约33.98%），医学研究与技术服务...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731190143a6cb886c&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>诺禾致源中标单细胞转录组二代测序项目 券商积极评价彰显成长潜力</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n诺禾致源中标单细胞转录组二代测序项目 券商积极评价彰显成长潜力\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-31 19:01 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731190143a6cb886c&s=b><strong>自选股中标信息</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>2025年07月31日，据天眼查数据，单细胞转录组二代测序（WLU-FW-KS-NM-2025-0795）成交结果公告显示，中标方为诺禾致源（sh688315），招标方为西湖大学。近半年内，诺禾致源获得6家券商积极评价：国盛证券和银河证券给予\"买入\"评级。浙商证券给予\"增持\"评级。诺禾致源主营业务涵盖测序平台服务（占比约50.00%），生命科学基础科研服务（占比约33.98%），医学研究与技术服务...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731190143a6cb886c&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"688315","symbol_name":"诺禾致源","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731190143a6cb886c&s=b","article_id":"2555887903","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731190143a6cb886c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2555887903","pubTimestamp":1753959697,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"2025年07月31日，据天眼查数据，单细胞转录组二代测序成交结果公告显示，中标方为诺禾致源，招标方为西湖大学。近半年内，诺禾致源获得6家券商积极评价：国盛证券和银河证券给予\"买入\"评级。诺禾致源主营业务涵盖测序平台服务，生命科学基础科研服务，医学研究与技术服务，其他收入之和。截至发稿，诺禾致源股价报16.32元，下跌0.43%，成交额至1.23亿元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"688315":"诺禾致源","BK0216":"研究试验","BK0221":"专业技术"},"translate_title":"Nuohe Zhiyuan won the bid for the second-generation single-cell transcriptome sequencing project. Brokers positively evaluated it and demonstrated its growth potential","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688315":1},"content_text":"2025年07月31日，据天眼查数据，单细胞转录组二代测序（WLU-FW-KS-NM-2025-0795）成交结果公告显示，中标方为诺禾致源（sh688315），招标方为西湖大学。近半年内，诺禾致源获得6家券商积极评价：国盛证券和银河证券给予\"买入\"评级。浙商证券给予\"增持\"评级。诺禾致源主营业务涵盖测序平台服务（占比约50.00%），生命科学基础科研服务（占比约33.98%），医学研究与技术服务（占比约13.06%），其他收入之和（占比约2.96%）。截至发稿，诺禾致源股价报16.32元，下跌0.43%，成交额至1.23亿元（5日均值1.25亿元）。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。中标数据由天眼查提供，由程序或算法识别中标信息页面生成，可能与实际存在差异，不作为决策依据。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2555887903","isCrawlerRequest":true}

诺禾致源中标单细胞转录组二代测序项目 券商积极评价彰显成长潜力

精彩评论

诺禾致源中标单细胞转录组二代测序项目券商积极评价彰显成长潜力